Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failure

被引:19
作者
Cubbon, Richard M. [1 ]
Ruff, Naomi [1 ]
Groves, David [2 ,3 ]
Eleuteri, Antonio [2 ,3 ]
Denby, Christine [2 ,3 ]
Kearney, Lorraine [1 ]
Ali, Noman [1 ]
Walker, Andrew M. N. [1 ]
Jamil, Haqeel [1 ]
Gierula, John [1 ]
Gale, Chris P. [1 ]
Batin, Phillip D. [4 ]
Nolan, James [5 ]
Shah, Ajay M. [6 ]
Fox, Keith A. A. [7 ]
Sapsford, Robert J. [8 ]
Witte, Klaus K. [1 ]
Kearney, Mark T. [1 ]
机构
[1] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, LIGHT Labs, Clarendon Way, Leeds LS2 9JT, W Yorkshire, England
[2] Royal Liverpool Univ Hosp, Med Phys & Clin Engn Dept, Liverpool, Merseyside, England
[3] Univ Liverpool, Dept Phys, Liverpool L69 3BX, Merseyside, England
[4] Mid Yorkshire Hosp NHS Trust, Pinderfields Gen Hosp, Dept Cardiol, Wakefield, England
[5] Univ Hosp North Staffordshire, Stoke On Trent, Staffs, England
[6] Kings Coll London, BHF Ctr Excellence, London WC2R 2LS, England
[7] Univ Edinburgh, BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland
[8] Leeds Teaching Hosp NHS Trust, Leeds Gen Infirm, Dept Cardiol, Leeds, W Yorkshire, England
基金
美国国家卫生研究院;
关键词
RATE-VARIABILITY; BETA-BLOCKADE; DEATH; TRIAL; ASSOCIATION; DYSFUNCTION; VALIDATION; MANAGEMENT; PROGNOSIS; RECOVERY;
D O I
10.1136/heartjnl-2015-308428
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective We aimed to define the prognostic value of the heart rate range during a 24 h period in patients with chronic heart failure (CHF). Methods Prospective observational cohort study of 791 patients with CHF associated with left ventricular systolic dysfunction. Mode-specific mortality and hospitalisation were linked with ambulatory heart rate range (AHRR; calculated as maximum minus minimum heart rate using 24 h Holter monitor data, including paced and non-sinus complexes) in univariate and multivariate analyses. Findings were then corroborated in a validation cohort of 408 patients with CHF with preserved or reduced left ventricular ejection fraction. Results After a mean 4.1 years of follow-up, increasing AHRR was associated with reduced risk of all-cause, sudden, non-cardiovascular and progressive heart failure death in univariate analyses. After accounting for characteristics that differed between groups above and below median AHRR using multivariate analysis, AHRR remained strongly associated with all-cause mortality (HR 0.991/bpm increase in AHRR (95% CI 0.999 to 0.982); p=0.046). AHRR was not associated with the risk of any non-elective hospitalisation, but was associated with heart-failure-related hospitalisation. AHRR was modestly associated with the SD of normal-to-normal beats (R-2=0.2; p<0.001) and with peak exercise-test heart rate (R-2=0.33; p<0.001). Analysis of the validation cohort revealed AHRR to be associated with all-cause and mode-specific death as described in the derivation cohort. Conclusions AHRR is a novel and readily available prognosticator in patients with CHF, which may reflect autonomic tone and exercise capacity.
引用
收藏
页码:223 / 229
页数:7
相关论文
共 19 条
[1]   Disease management: remote monitoring in heart failure patients with implantable defibrillators, resynchronization devices, and haemodynamic monitors [J].
Abraham, William T. .
EUROPACE, 2013, 15 :40-46
[2]   The prognostic value of the heart rate response during exercise and recovery in patients with heart failure: Influence of beta-blockade [J].
Arena, Ross ;
Myers, Jonathan ;
Abella, Joshua ;
Peberdy, Mary Ann ;
Bensimhon, Daniel ;
Chase, Paul ;
Guazzi, Marco .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 138 (02) :166-173
[3]   Heart rate: surrogate or target in the management of heart failure? [J].
Boehm, Michael ;
Reil, Jan-Christian .
HEART, 2013, 99 (02) :72-75
[4]  
Böhm M, 2010, LANCET, V376, P886, DOI 10.1016/S0140-6736(10)61259-7
[5]   Cardiopulmonary exercise testing and prognosis in heart failure due to systolic left ventricular dysfunction: a validation study of the European Society of Cardiology Guidelines and Recommendations (2008) and further developments [J].
Corra, Ugo ;
Giordano, Andrea ;
Mezzani, Alessandro ;
Gnemmi, Marco ;
Pistono, Massimo ;
Caruso, Roberto ;
Giannuzzi, Pantaleo .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2012, 19 (01) :32-40
[6]   Prospective development and validation of a model to predict heart failure hospitalisation [J].
Cubbon, R. M. ;
Woolston, A. ;
Adams, B. ;
Gale, C. P. ;
Gilthorpe, M. S. ;
Baxter, P. D. ;
Kearney, L. C. ;
Mercer, B. ;
Rajwani, A. ;
Batin, P. D. ;
Kahn, M. ;
Sapsford, R. J. ;
Witte, K. K. ;
Kearney, M. T. .
HEART, 2014, 100 (12) :923-929
[7]   Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology [J].
Cubbon, Richard M. ;
Adams, Brook ;
Rajwani, Adil ;
Mercer, Ben N. ;
Patel, Peysh A. ;
Gherardi, Guy ;
Gale, Christopher P. ;
Batin, Phillip D. ;
Ajjan, Ramzi ;
Kearney, Lorraine ;
Wheatcroft, Stephen B. ;
Sapsford, Robert J. ;
Witte, Klaus K. ;
Kearney, Mark T. .
DIABETES & VASCULAR DISEASE RESEARCH, 2013, 10 (04) :330-336
[8]   Changing Characteristics and Mode of Death Associated With Chronic Heart Failure Caused by Left Ventricular Systolic Dysfunction A Study Across Therapeutic Eras [J].
Cubbon, Richard M. ;
Gale, Christopher P. ;
Kearney, Lorraine C. ;
Schechter, Clyde B. ;
Brooksby, W. Paul ;
Nolan, Jim ;
Fox, Keith A. A. ;
Rajwani, Adil ;
Baig, Wazir ;
Groves, David ;
Barlow, Pauline ;
Fisher, Anthony C. ;
Batin, Phillip D. ;
Kahn, Matthew B. ;
Zaman, Azfar G. ;
Shah, Ajay M. ;
Byrne, Jon A. ;
Lindsay, Steven J. ;
Sapsford, Robert J. ;
Wheatcroft, Stephen B. ;
Witte, Klaus K. ;
Kearney, Mark T. .
CIRCULATION-HEART FAILURE, 2011, 4 (04) :396-+
[9]   Heart rate achieved or beta-blocker dose in patients with chronic heart failure: which is the better target? [J].
Cullington, Damien ;
Goode, Kevin M. ;
Clark, Andrew L. ;
Cleland, John G. F. .
EUROPEAN JOURNAL OF HEART FAILURE, 2012, 14 (07) :737-747
[10]   Association between resting heart rate, chronotropic index, and long-term outcomes in patients with heart failure receiving -blocker therapy: data from the HF-ACTION trial [J].
Dobre, Daniela ;
Zannad, Faiez ;
Keteyian, Steven J. ;
Stevens, Susanna R. ;
Rossignol, Patrick ;
Kitzman, Dalane W. ;
Landzberg, Joel ;
Howlett, Jonathan ;
Kraus, William E. ;
Ellis, Stephen J. .
EUROPEAN HEART JOURNAL, 2013, 34 (29) :2271-2280